Bill
A 2648
Bill A 2648 ensures public schools stock epinephrine auto-injectors and train staff, enhancing safety for students at risk of severe allergic reactions.
Bill Number: A 2648
Title: Provides Public Access to Epinephrine Auto-Injector Devices at Schools
Status: Referred to Education
Introduced: January 21, 2025
Classification: Bill
Bill A 2648 aims to enhance the safety and health of students in schools by ensuring that epinephrine auto-injector devices (commonly known as EpiPens) are readily available on school premises. The bill recognizes the increasing prevalence of severe allergic reactions among children and seeks to provide immediate access to life-saving medication in emergency situations.
Availability of EpiPens: The bill mandates that all public schools must maintain a supply of epinephrine auto-injectors on-site. This requirement is intended to ensure that students experiencing anaphylaxis can receive prompt treatment.
Training Requirements: School personnel will be required to undergo training on how to recognize the signs of anaphylaxis and properly administer the epinephrine auto-injectors. This training aims to prepare staff to respond effectively in emergencies.
Policy Development: Schools will be tasked with developing policies regarding the storage, maintenance, and administration of epinephrine auto-injectors. These policies will ensure that the devices are kept in accessible locations and are regularly checked for expiration dates.
Liability Protections: The bill includes provisions that protect school staff from liability when administering epinephrine auto-injectors in good faith during an emergency.
Students: The primary beneficiaries of this bill are students with known allergies who are at risk of anaphylaxis. The availability of EpiPens can significantly reduce the risk of severe health complications or fatalities.
School Staff: Teachers and other school personnel will be directly impacted as they will need to participate in training and adhere to new policies regarding the use of epinephrine auto-injectors.
Parents and Guardians: Families of students with allergies may find reassurance in knowing that schools are equipped to handle allergic emergencies effectively.
Current Status: As of January 21, 2025, the bill has been referred to the Education Committee for further discussion and evaluation.
Related Legislation: Bill A 2648 is related to prior-session Bill A 4909 and has a companion bill, S 5589, which may provide additional context or support for its provisions.
Bill A 2648 represents a proactive approach to managing allergic reactions in schools by ensuring that epinephrine auto-injectors are accessible and that staff are trained to use them. If enacted, this legislation could significantly improve the safety and health outcomes for students with severe allergies.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
